Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas
Clinical trial NCT00493467 · COMPLETED
Trial details
- NCT number
- NCT00493467
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2015-04-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.